Mitoxantrone Hydrochloride contains not less than 97.0% and not more than 102.0% of C22H28N4O6‧2HCl, calculated on the anhydrous basis.

共有 1 個藥物證書使用此成份

申請商
東信化學藥品有限公司 
適應症
抗腫瘤藥
含量
發證日期
2015-10-22